Debora Lorenzon

825 total citations
15 papers, 669 citations indexed

About

Debora Lorenzon is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Debora Lorenzon has authored 15 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Debora Lorenzon's work include Lymphoma Diagnosis and Treatment (5 papers), Metal complexes synthesis and properties (4 papers) and Immune Cell Function and Interaction (3 papers). Debora Lorenzon is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Metal complexes synthesis and properties (4 papers) and Immune Cell Function and Interaction (3 papers). Debora Lorenzon collaborates with scholars based in Italy, Ukraine and Switzerland. Debora Lorenzon's co-authors include Donatella Aldinucci, Dolores Fregona, Alfonso Colombatti, Lorena Giovagnini, Antonio Pinto, Annunziata Gloghini, Antonino Carbone, S. Sitran, Luca Ronconi and Valter Gattei and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Debora Lorenzon

14 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debora Lorenzon Italy 11 399 255 238 171 131 15 669
Naike Casagrande Italy 16 538 1.3× 367 1.4× 151 0.6× 127 0.7× 46 0.4× 24 974
Leland C. Burrill United States 7 135 0.3× 106 0.4× 187 0.8× 231 1.4× 309 2.4× 7 688
Rachel Dobson United Kingdom 8 119 0.3× 77 0.3× 99 0.4× 46 0.3× 119 0.9× 10 362
Neil Wishart United States 13 132 0.3× 207 0.8× 40 0.2× 259 1.5× 56 0.4× 21 799
Rohan Mendonca United States 8 159 0.4× 116 0.5× 187 0.8× 159 0.9× 316 2.4× 8 717
Linda Kessler United States 14 352 0.9× 127 0.5× 62 0.3× 137 0.8× 49 0.4× 38 1.1k
Christoph A. Schatz Germany 15 525 1.3× 84 0.3× 108 0.5× 108 0.6× 135 1.0× 47 1.2k
Janis Upeslacis United States 10 595 1.5× 128 0.5× 58 0.2× 275 1.6× 80 0.6× 11 1.2k
Jordan M. Chinai United States 10 734 1.8× 586 2.3× 46 0.2× 197 1.2× 40 0.3× 11 1.3k
Ogan D. Abaan United States 11 298 0.7× 119 0.5× 221 0.9× 60 0.4× 147 1.1× 14 1.2k

Countries citing papers authored by Debora Lorenzon

Since Specialization
Citations

This map shows the geographic impact of Debora Lorenzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora Lorenzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora Lorenzon more than expected).

Fields of papers citing papers by Debora Lorenzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora Lorenzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora Lorenzon. The network helps show where Debora Lorenzon may publish in the future.

Co-authorship network of co-authors of Debora Lorenzon

This figure shows the co-authorship network connecting the top 25 collaborators of Debora Lorenzon. A scholar is included among the top collaborators of Debora Lorenzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora Lorenzon. Debora Lorenzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Boscutti, Giulia, Debora Lorenzon, S. Sitran, et al.. (2012). t-Butylsarcosinedithiocarbamato gold(III)-based anticancer agents: Design, in vitro biological evaluation and interaction with model biomolecules. Inorganica Chimica Acta. 393. 304–317. 17 indexed citations
2.
Zucchetto, Antonella, Dania Benedetti, Claudio Tripodo, et al.. (2009). CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival. Cancer Research. 69(9). 4001–4009. 118 indexed citations
3.
Gloghini, Annunziata, Raffaele Di Francia, Debora Lorenzon, et al.. (2009). Functional coexpression of Interleukin (IL)‐7 and its receptor (IL‐7R) on Hodgkin and Reed‐Sternberg cells: Involvement of IL‐7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. International Journal of Cancer. 125(5). 1092–1101. 73 indexed citations
4.
Lorenzon, Debora, Tiziana Perin, Pietro Bulian, et al.. (2009). Human immunodeficiency virus–associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Human Pathology. 40(7). 1045–1049.
5.
Abbruzzese, Laura, Mariagrazia Michieli, Maurizio Rupolo, et al.. (2009). A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience. Vox Sanguinis. 98(2). 172–180. 11 indexed citations
6.
Aldinucci, Donatella, et al.. (2009). IRF4 is modulated by CD40L and by apoptotic and anti‐proliferative signals in Hodgkin lymphoma. British Journal of Haematology. 148(1). 115–118. 17 indexed citations
7.
Lorenzon, Debora, M. Mazzucato, Laura Abbruzzese, et al.. (2008). Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony‐stimulating factor. Vox Sanguinis. 94(4). 342–350. 2 indexed citations
8.
Aldinucci, Donatella, et al.. (2008). Antiproliferative and Apoptotic Effects of Two New Pd(II) Methylsarcosinedithiocarbamate Derivatives on Human Acute Myeloid Leukemia Cells In Vitro. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(3). 103–113. 5 indexed citations
9.
Aldinucci, Donatella, Debora Lorenzon, Antonio Pinto, et al.. (2007). Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer. 122(4). 769–776. 123 indexed citations
10.
11.
Giovagnini, Lorena, Luca Ronconi, Donatella Aldinucci, et al.. (2005). Synthesis, Characterization, and Comparative in Vitro Cytotoxicity Studies of Platinum(II), Palladium(II), and Gold(III) Methylsarcosinedithiocarbamate Complexes. Journal of Medicinal Chemistry. 48(5). 1588–1595. 162 indexed citations
12.
Aldinucci, Donatella, et al.. (2004). Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells. Leukemia & lymphoma. 45(9). 1731–1739. 39 indexed citations
13.
Aldinucci, Donatella, et al.. (2004). The role of interleukin-3 in classical Hodgkin's disease. Leukemia & lymphoma. 46(3). 303–311. 29 indexed citations
14.
Aldinucci, Donatella, Debora Lorenzon, Paola Nanni, et al.. (2004). CD26 Expression Correlates with a Reduced Sensitivity to 2′-Deoxycoformycin-Induced Growth Inhibition and Apoptosis in T-Cell Leukemia/Lymphomas. Clinical Cancer Research. 10(2). 508–520. 24 indexed citations
15.
Giacobini, Ezio, et al.. (1986). Esophageal dischalasia: Serendipity during 99mTc thyroid scan. European Journal of Nuclear Medicine and Molecular Imaging. 11(12). 505–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026